Merav Bassan - 29 Oct 2023 Form 4 Insider Report for BiomX Inc. (PHGE)

Role: Chief Development Officer
Signature: /s/ Merav Bassan
Issuer symbol: PHGE
Transactions as of: 29 Oct 2023
Net transactions value: $0
Form type: 4
Filing time: 31 Oct 2023, 17:13:55 UTC
Previous filing: 03 Mar 2023
Next filing: 13 Dec 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PHGE	Common Stock Options - Right to Buy	Disposed to Issuer	$0	-189,997	-100%	$0.000000^*	0	29 Oct 2023	Common Stock	0	$10.00	Direct	F1
transaction	PHGE	Common Stock Options - Right to Buy	Award	$0	+189,997		$0.000000^*	0	29 Oct 2023	Common Stock	0	$0.2750	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 10/10/2019 and provides for vesting over four years, with 25% of the shares subject to the option vested on 10/10/2020, and the remainder vesting in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024.

Content

The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 10/10/2019 and provides for vesting over four years, with 25% of the shares subject to the option vested on 10/10/2020, and the remainder vesting in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024.